The effects of hypnosis, context reinstatement, and anxiety on eyewitness memory von Ready, David J., Bothwell, Robert K., Brigham, John C.

Volltext

Should there be a clinical typology of posttraumatic stress disorder? von Alarcon, R D, Deering, C G, Glover, S G, Ready, D J, Eddleman, H C

Volltext

Standards for Evaluating the Fairness of Photograph Lineups von Brigham, John C., Ready, David J., Spier, Stacy A.

Volltext

Should there be a clinical typology of posttraumatic stress disorder. Comments von ALARCON, R. D, DEERING, C. G, GLOVER, S. G, READY, D. J, EDDLEMAN, H. C, MIDDLETON, W, O'TOOLE, B. I

Volltext

Own-Race Bias in Lineup Construction von Brigham, John C, Ready, David J

Volltext

Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study von Hellmann, Matthew D, Dr, Rizvi, Naiyer A, Prof, Goldman, Jonathan W, MD, Gettinger, Scott N, MD, Borghaei, Hossein, DO, Brahmer, Julie R, MD, Ready, Neal E, Prof, Gerber, David E, MD, Chow, Laura Q, MD, Juergens, Rosalyn A, MD, Shepherd, Frances A, Prof, Laurie, Scott A, MD, Geese, William J, PhD, Agrawal, Shruti, PhD, Young, Tina C, MS, Li, Xuemei, MD, Antonia, Scott J, Prof

Volltext

The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis von Walker, A K, Rivera, P D, Wang, Q, Chuang, J-C, Tran, S, Osborne-Lawrence, S, Estill, S J, Starwalt, R, Huntington, P, Morlock, L, Naidoo, J, Williams, N S, Ready, J M, Eisch, A J, Pieper, A A, Zigman, J M

Volltext

Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases von Vokes, E.E., Ready, N., Felip, E., Horn, L., Burgio, M.A., Antonia, S.J., Arén Frontera, O., Gettinger, S., Holgado, E., Spigel, D., Waterhouse, D., Domine, M., Garassino, M., Chow, L.Q.M., Blumenschein, G., Barlesi, F., Coudert, B., Gainor, J., Arrieta, O., Brahmer, J., Butts, C., Steins, M., Geese, W.J., Li, A., Healey, D., Crinò, L.

Volltext

Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort von Ready, Neal E., Ott, Patrick A., Hellmann, Matthew D., Zugazagoitia, Jon, Hann, Christine L., de Braud, Filippo, Antonia, Scott J., Ascierto, Paolo A., Moreno, Victor, Atmaca, Akin, Salvagni, Stefania, Taylor, Matthew, Amin, Asim, Camidge, D. Ross, Horn, Leora, Calvo, Emiliano, Li, Ang, Lin, Wen Hong, Callahan, Margaret K., Spigel, David R.

Volltext

Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study von Rudin, Charles M, Prof, Pietanza, M Catherine, MD, Bauer, Todd M, MD, Ready, Neal, Prof, Morgensztern, Daniel, MD, Glisson, Bonnie S, Prof, Byers, Lauren A, MD, Johnson, Melissa L, MD, Burris, Howard A, MD, Robert, Francisco, Prof, Han, Tae H, PhD, Bheddah, Sheila, BA, Theiss, Noah, MS, Watson, Sky, BS, Mathur, Deepan, MD, Vennapusa, Bharathi, MD, Zayed, Hany, PhD, Lally, Satwant, MS, Strickland, Donald K, MD, Govindan, Ramaswamy, Prof, Dylla, Scott J, PhD, Peng, Stanford L, MD, Spigel, David R, MD

Volltext

First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers von Ready, Neal, Hellmann, Matthew D, Awad, Mark M, Otterson, Gregory A, Gutierrez, Martin, Gainor, Justin F, Borghaei, Hossein, Jolivet, Jacques, Horn, Leora, Mates, Mihaela, Brahmer, Julie, Rabinowitz, Ian, Reddy, Pavan S, Chesney, Jason, Orcutt, James, Spigel, David R, Reck, Martin, O'Byrne, Kenneth John, Paz-Ares, Luis, Hu, Wenhua, Zerba, Kim, Li, Xuemei, Lestini, Brian, Geese, William J, Szustakowski, Joseph D, Green, George, Chang, Han, Ramalingam, Suresh S

Volltext

Small molecule inhibitors of 15-PGDH exploit a physiologic induced-fit closing system von Huang, Wei, Li, Hongyun, Kiselar, Janna, Fink, Stephen P., Regmi, Sagar, Day, Alexander, Yuan, Yiyuan, Chance, Mark, Ready, Joseph M., Markowitz, Sanford D., Taylor, Derek J.

Volltext

Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a pooled analysis von Borghaei, H., Ciuleanu, T.-E., Lee, J.-S., Pluzanski, A., Caro, R. Bernabe, Gutierrez, M., Ohe, Y., Nishio, M., Goldman, J., Ready, N., Spigel, D.R., Ramalingam, S.S., Paz-Ares, L.G., Gainor, J.F., Ahmed, S., Reck, M., Maio, M., O’Byrne, K.J., Memaj, A., Nathan, F., Tran, P., Hellmann, M.D., Brahmer, J.R.

Volltext

Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C Infection von McHutchison, John G, Lawitz, Eric J, Shiffman, Mitchell L, Muir, Andrew J, Galler, Greg W, McCone, Jonathan, Nyberg, Lisa M, Lee, William M, Ghalib, Reem H, Schiff, Eugene R, Galati, Joseph S, Bacon, Bruce R, Davis, Mitchell N, Mukhopadhyay, Pabak, Koury, Kenneth, Noviello, Stephanie, Pedicone, Lisa D, Brass, Clifford A, Albrecht, Janice K, Sulkowski, Mark S

Volltext

Detection, survival, and persistence of Staphylococcus capitis NRCS-A in neonatal units in England von Moore, G., Barry, A., Carter, J., Ready, J., Wan, Y., Elsayed, M., Haill, C., Khashu, M., Williams, O.M., Brown, C.S., Demirjian, A., Ready, D.

Volltext

Evidence summary: the relationship between oral and cardiovascular disease von Dietrich, T., Webb, I., Stenhouse, L., Pattni, A., Ready, D., Wanyonyi, K. L., White, S., Gallagher, J. E.

Volltext

Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032 von Ready, Neal, Farago, Anna F., de Braud, Filippo, Atmaca, Akin, Hellmann, Matthew D., Schneider, Jeffrey G., Spigel, David R., Moreno, Victor, Chau, Ian, Hann, Christine L., Eder, Joseph Paul, Steele, Nicola L., Pieters, Anne, Fairchild, Justin, Antonia, Scott J.

Volltext

Tuning Thermal Expansion in Metal–Organic Frameworks Using a Mixed Linker Solid Solution Approach von Baxter, Samuel J, Schneemann, Andreas, Ready, Austin D, Wijeratne, Pavithra, Wilkinson, Angus P, Burtch, Nicholas C

Volltext

Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer von Borghaei, Hossein, Paz-Ares, Luis, Horn, Leora, Spigel, David R, Steins, Martin, Ready, Neal E, Chow, Laura Q, Vokes, Everett E, Felip, Enriqueta, Holgado, Esther, Barlesi, Fabrice, Kohlhäufl, Martin, Arrieta, Oscar, Burgio, Marco Angelo, Fayette, Jérôme, Lena, Hervé, Poddubskaya, Elena, Gerber, David E, Gettinger, Scott N, Rudin, Charles M, Rizvi, Naiyer, Crinò, Lucio, Blumenschein, George R, Antonia, Scott J, Dorange, Cécile, Harbison, Christopher T, Graf Finckenstein, Friedrich, Brahmer, Julie R

Volltext

Immune Activation in Early-Stage Non-Small Cell Lung Cancer Patients Receiving Neoadjuvant Chemotherapy Plus Ipilimumab von Yi, John S, Ready, Neal, Healy, Patrick, Dumbauld, Chelsae, Osborne, Robyn, Berry, Mark, Shoemaker, Debra, Clarke, Jeffrey, Crawford, Jeffrey, Tong, Betty, Harpole, David, D'Amico, Thomas A, McSherry, Frances, Dunphy, Frank, McCall, Shannon J, Christensen, Jared D, Wang, Xiaofei, Weinhold, Kent J

Volltext